v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Stockholders' Equity, Beginning Balance at Dec. 31, 2024 $ 299,760 $ 55 $ 626,296 $ (407) $ (326,184)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   54,731,316      
Exercises of stock options 82   82    
Exercises of stock options (in shares)   27,613      
Vesting of restricted stock units (in shares)   450,556      
Stock-based compensation expense 3,673   3,673    
Unrealized gain (loss) on available-for-sale securities, net of tax 208     208  
Net loss (31,021)       (31,021)
Stockholders' Equity, Ending Balance at Mar. 31, 2025 272,702 $ 55 630,051 (199) (357,205)
Shares, Outstanding, Ending Balance at Mar. 31, 2025   55,209,485      
Stockholders' Equity, Beginning Balance at Dec. 31, 2024 299,760 $ 55 626,296 (407) (326,184)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   54,731,316      
Unrealized gain (loss) on available-for-sale securities, net of tax 186        
Net loss (64,403)        
Stockholders' Equity, Ending Balance at Jun. 30, 2025 243,944 $ 56 634,696 (221) (390,587)
Shares, Outstanding, Ending Balance at Jun. 30, 2025   55,434,956      
Stockholders' Equity, Beginning Balance at Mar. 31, 2025 272,702 $ 55 630,051 (199) (357,205)
Shares, Outstanding, Beginning Balance at Mar. 31, 2025   55,209,485      
Exercises of stock options 79 $ 1 78    
Exercises of stock options (in shares)   27,433      
Vesting of restricted stock units (in shares)   99,528      
Issuance of common stock under ESPP 434   434    
Issuance of common stock under ESPP (in shares)   98,510      
Stock-based compensation expense 4,133   4,133    
Unrealized gain (loss) on available-for-sale securities, net of tax (22)     (22)  
Net loss (33,382)       (33,382)
Stockholders' Equity, Ending Balance at Jun. 30, 2025 243,944 $ 56 634,696 (221) (390,587)
Shares, Outstanding, Ending Balance at Jun. 30, 2025   55,434,956      
Stockholders' Equity, Beginning Balance at Dec. 31, 2025 196,081 $ 59 641,895 32 (445,905)
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   59,047,860      
Exercises of stock options 294   294    
Exercises of stock options (in shares)   87,081      
Vesting of restricted stock units (in shares)   545,015      
Issuance of common stock from at-the-market sales agreement, net of issuance costs 3,038 $ 1 3,037    
Issuance of common stock from at-the-market sales agreement, net of issuance costs (in shares)   630,570      
Stock-based compensation expense 2,488   2,488    
Unrealized gain (loss) on available-for-sale securities, net of tax (295)     (295)  
Net loss (27,937)       (27,937)
Stockholders' Equity, Ending Balance at Mar. 31, 2026 173,669 $ 60 647,714 (263) (473,842)
Shares, Outstanding, Ending Balance at Mar. 31, 2026   60,310,526      
Stockholders' Equity, Beginning Balance at Dec. 31, 2025 $ 196,081 $ 59 641,895 32 (445,905)
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   59,047,860      
Exercises of stock options (in shares) 192,931        
Unrealized gain (loss) on available-for-sale securities, net of tax $ (453)        
Net loss (52,410)        
Stockholders' Equity, Ending Balance at Jun. 30, 2026 154,377 $ 61 653,052 (421) (498,315)
Shares, Outstanding, Ending Balance at Jun. 30, 2026   61,273,390      
Stockholders' Equity, Beginning Balance at Mar. 31, 2026 173,669 $ 60 647,714 (263) (473,842)
Shares, Outstanding, Beginning Balance at Mar. 31, 2026   60,310,526      
Exercises of stock options 57   57    
Exercises of stock options (in shares)   105,481      
Vesting of restricted stock units (in shares)   55,914      
Issuance of common stock under ESPP 219   219    
Issuance of common stock under ESPP (in shares)   73,473      
Issuance of common stock from at-the-market sales agreement, net of issuance costs 2,630 $ 1 2,629    
Issuance of common stock from at-the-market sales agreement, net of issuance costs (in shares)   727,996      
Stock-based compensation expense 2,433   2,433    
Unrealized gain (loss) on available-for-sale securities, net of tax (158)     (158)  
Net loss (24,473)       (24,473)
Stockholders' Equity, Ending Balance at Jun. 30, 2026 $ 154,377 $ 61 $ 653,052 $ (421) $ (498,315)
Shares, Outstanding, Ending Balance at Jun. 30, 2026   61,273,390